vs

Side-by-side financial comparison of CODEXIS, INC. (CDXS) and LINKBANCORP, Inc. (LNKB). Click either name above to swap in a different company.

LINKBANCORP, Inc. is the larger business by last-quarter revenue ($46.0M vs $38.9M, roughly 1.2× CODEXIS, INC.). CODEXIS, INC. runs the higher net margin — 24.7% vs 6.4%, a 18.3% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs 7.3%). LINKBANCORP, Inc. produced more free cash flow last quarter ($23.8M vs $19.6M). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs 6.6%).

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

LINKBANCORP, Inc. is a US-based bank holding company that offers comprehensive retail and commercial banking services to individual consumers, small businesses, and mid-sized enterprises. Its core offerings include deposit accounts, lending products, wealth management solutions, and digital banking services, primarily serving customers across regional markets in Pennsylvania.

CDXS vs LNKB — Head-to-Head

Bigger by revenue
LNKB
LNKB
1.2× larger
LNKB
$46.0M
$38.9M
CDXS
Growing faster (revenue YoY)
CDXS
CDXS
+74.1% gap
CDXS
81.3%
7.3%
LNKB
Higher net margin
CDXS
CDXS
18.3% more per $
CDXS
24.7%
6.4%
LNKB
More free cash flow
LNKB
LNKB
$4.2M more FCF
LNKB
$23.8M
$19.6M
CDXS
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
6.6%
LNKB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CDXS
CDXS
LNKB
LNKB
Revenue
$38.9M
$46.0M
Net Profit
$9.6M
$2.9M
Gross Margin
94.8%
Operating Margin
27.1%
8.5%
Net Margin
24.7%
6.4%
Revenue YoY
81.3%
7.3%
Net Profit YoY
192.5%
-61.2%
EPS (diluted)
$0.13
$0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDXS
CDXS
LNKB
LNKB
Q4 25
$38.9M
$46.0M
Q3 25
$8.6M
$44.8M
Q2 25
$15.3M
$42.3M
Q1 25
$7.5M
$53.4M
Q4 24
$21.5M
$42.9M
Q3 24
$12.8M
$42.9M
Q2 24
$8.0M
$41.3M
Q1 24
$17.1M
$40.5M
Net Profit
CDXS
CDXS
LNKB
LNKB
Q4 25
$9.6M
$2.9M
Q3 25
$-19.6M
$7.8M
Q2 25
$-13.3M
$7.4M
Q1 25
$-20.7M
$15.3M
Q4 24
$-10.4M
$7.6M
Q3 24
$-20.6M
$7.1M
Q2 24
$-22.8M
$5.8M
Q1 24
$-11.5M
$5.7M
Gross Margin
CDXS
CDXS
LNKB
LNKB
Q4 25
94.8%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
Q3 24
66.4%
Q2 24
56.6%
Q1 24
71.6%
Operating Margin
CDXS
CDXS
LNKB
LNKB
Q4 25
27.1%
8.5%
Q3 25
-220.3%
22.3%
Q2 25
-83.9%
22.4%
Q1 25
-271.6%
36.0%
Q4 24
-34.2%
22.6%
Q3 24
-129.0%
21.3%
Q2 24
-284.9%
18.0%
Q1 24
-69.6%
18.1%
Net Margin
CDXS
CDXS
LNKB
LNKB
Q4 25
24.7%
6.4%
Q3 25
-228.1%
17.5%
Q2 25
-86.6%
17.5%
Q1 25
-274.3%
28.7%
Q4 24
-48.4%
17.7%
Q3 24
-160.8%
16.5%
Q2 24
-285.2%
14.1%
Q1 24
-67.4%
14.1%
EPS (diluted)
CDXS
CDXS
LNKB
LNKB
Q4 25
$0.13
$0.08
Q3 25
$-0.22
$0.21
Q2 25
$-0.16
$0.20
Q1 25
$-0.25
$0.41
Q4 24
$-0.12
$0.21
Q3 24
$-0.29
$0.19
Q2 24
$-0.32
$0.16
Q1 24
$-0.16
$0.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDXS
CDXS
LNKB
LNKB
Cash + ST InvestmentsLiquidity on hand
$78.2M
$52.3M
Total DebtLower is stronger
$40.1M
$177.3M
Stockholders' EquityBook value
$50.5M
$306.4M
Total Assets
$147.8M
$3.1B
Debt / EquityLower = less leverage
0.79×
0.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDXS
CDXS
LNKB
LNKB
Q4 25
$78.2M
$52.3M
Q3 25
$58.7M
$194.2M
Q2 25
$66.3M
$155.1M
Q1 25
$59.8M
$220.2M
Q4 24
$73.5M
$166.1M
Q3 24
$90.3M
$191.2M
Q2 24
$73.2M
$181.7M
Q1 24
$85.5M
$172.3M
Total Debt
CDXS
CDXS
LNKB
LNKB
Q4 25
$40.1M
$177.3M
Q3 25
$39.7M
$102.3M
Q2 25
$39.4M
$102.3M
Q1 25
$29.2M
$102.7M
Q4 24
$28.9M
$112.5M
Q3 24
$28.6M
$102.4M
Q2 24
$28.4M
$102.3M
Q1 24
$28.1M
$102.2M
Stockholders' Equity
CDXS
CDXS
LNKB
LNKB
Q4 25
$50.5M
$306.4M
Q3 25
$38.5M
$305.5M
Q2 25
$55.6M
$298.0M
Q1 25
$49.6M
$294.1M
Q4 24
$66.9M
$280.2M
Q3 24
$73.4M
$277.4M
Q2 24
$61.4M
$271.4M
Q1 24
$79.3M
$268.2M
Total Assets
CDXS
CDXS
LNKB
LNKB
Q4 25
$147.8M
$3.1B
Q3 25
$124.0M
$3.1B
Q2 25
$138.2M
$2.9B
Q1 25
$128.9M
$2.9B
Q4 24
$149.0M
$2.9B
Q3 24
$148.2M
$2.9B
Q2 24
$132.0M
$2.9B
Q1 24
$149.6M
$2.8B
Debt / Equity
CDXS
CDXS
LNKB
LNKB
Q4 25
0.79×
0.58×
Q3 25
1.03×
0.33×
Q2 25
0.71×
0.34×
Q1 25
0.59×
0.35×
Q4 24
0.43×
0.40×
Q3 24
0.39×
0.37×
Q2 24
0.46×
0.38×
Q1 24
0.35×
0.38×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDXS
CDXS
LNKB
LNKB
Operating Cash FlowLast quarter
$20.1M
$25.3M
Free Cash FlowOCF − Capex
$19.6M
$23.8M
FCF MarginFCF / Revenue
50.3%
51.7%
Capex IntensityCapex / Revenue
1.3%
3.2%
Cash ConversionOCF / Net Profit
2.09×
8.59×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M
$55.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDXS
CDXS
LNKB
LNKB
Q4 25
$20.1M
$25.3M
Q3 25
$-7.7M
$23.6M
Q2 25
$-18.0M
$6.3M
Q1 25
$-13.8M
$2.6M
Q4 24
$-16.5M
$25.4M
Q3 24
$-13.0M
$14.0M
Q2 24
$-12.2M
$6.4M
Q1 24
$-7.8M
$-771.0K
Free Cash Flow
CDXS
CDXS
LNKB
LNKB
Q4 25
$19.6M
$23.8M
Q3 25
$-7.9M
$23.2M
Q2 25
$-20.5M
$6.1M
Q1 25
$-15.1M
$2.2M
Q4 24
$-18.2M
$22.6M
Q3 24
$-14.0M
$13.1M
Q2 24
$-12.6M
$6.3M
Q1 24
$-8.9M
$-1.2M
FCF Margin
CDXS
CDXS
LNKB
LNKB
Q4 25
50.3%
51.7%
Q3 25
-91.7%
51.8%
Q2 25
-133.6%
14.5%
Q1 25
-199.6%
4.2%
Q4 24
-85.0%
52.6%
Q3 24
-109.0%
30.5%
Q2 24
-157.5%
15.3%
Q1 24
-52.2%
-3.0%
Capex Intensity
CDXS
CDXS
LNKB
LNKB
Q4 25
1.3%
3.2%
Q3 25
2.1%
0.8%
Q2 25
16.4%
0.4%
Q1 25
16.7%
0.7%
Q4 24
8.3%
6.7%
Q3 24
7.8%
2.1%
Q2 24
5.0%
0.1%
Q1 24
6.6%
1.1%
Cash Conversion
CDXS
CDXS
LNKB
LNKB
Q4 25
2.09×
8.59×
Q3 25
3.01×
Q2 25
0.85×
Q1 25
0.17×
Q4 24
3.35×
Q3 24
1.97×
Q2 24
1.10×
Q1 24
-0.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons